Global Digestive & Intestinal Remedies Market Size study & Forecast, by Type (Digestive Medicines, Gastrointestinal Agents, and Remedies), by Age Group (Pediatric, Adult), by Distribution Channel (Online, Offline) and Regional Analysis, 2023-2030

Global Digestive & Intestinal Remedies Market Size study & Forecast, by Type (Digestive Medicines, Gastrointestinal Agents, and Remedies), by Age Group (Pediatric, Adult), by Distribution Channel (Online, Offline) and Regional Analysis, 2023-2030

Global Digestive & Intestinal Remedies Market is valued at approximately USD 18.5 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 3.5% over the forecast period 2023-2030. Digestive remedies are treatments that attempt to reduce the discomfort or symptoms produced by digestive issues. These treatments could include herbal supplements, or dietary changes that help the gastrointestinal tract perform more efficiently. They are commonly used to treat common digestive problems such as indigestion, bloating, constipation, diarrhea, heartburn, and irritable bowel syndrome. The increasing consumption in the fast-food industry can contribute to gastrointestinal disorders are the key factors responsible for the market growth of the Digestive & Intestinal Remedies Market over the forecast period 2023-2030.

The primary key factor anticipated to accelerate the growth of the Digestive & Intestinal Remedies Market is increasing consumption in the fast-food industry. In 2021, the annual revenue of the food segment is USD 339,717 million and the worldwide food industry is projected to grow to USD 468,201 million by the year 2025. Also, increasing healthcare expenditure and increased consumer focus on health will accelerate market growth. Moreover, an increase in funding for research and development and the growth of e-commerce is anticipated to create a positive outlook for the market. However, the high cost of treatment and availability of effective alternatives stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Digestive & Intestinal Remedies Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in terms of revenue owing to factors such as the increasing geriatric and obese population in this region. and increasing research and development activities by key market players boosting the market growth in the region. Asia-Pacific is the fastest-growing region due to the increasing demand for digestive & intestinal remedies medicine in this region and the increase in health issues leading to the rising demand for digestives & intestinal remedy types.

Major market player included in this report are:
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim International GmbH
Prestige Consumer Healthcare Inc
Taisho Pharmaceutical Holdings Co Ltd
Procter & Gamble Co.
Reckitt Benckiser Group PLC.
Bausch Health Companies Inc
Nestle S.A.
Haleon PLC
Sun Pharmaceutical Industries Ltd.

Recent Developments in the Market:
In Sep 2022, reckitt Benckiser Group Plc launched its first-of-its-kind microbiome brand, Bodi Ome. The probiotic dietary supplements include Immun N'me, Femme Power and Beating Heart,that product has many benefits such as all clinically proven, targeted probiotic strains to enhance digestive and immune health, heart health, and vaginal health.

Global Digestive & Intestinal Remedies Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Type, Age Group, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Digestive Medicines
Gastrointestinal Agents
Remedies

By Age Group:
Pediatric
Adult

By Distribution Channel
Online
Offline

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim International GmbH
Prestige Consumer Healthcare Inc
Taisho Pharmaceutical Holdings Co Ltd
Procter & Gamble Co.
Reckitt Benckiser Group PLC.
Bausch Health Companies Inc
Nestle S.A.
Haleon PLC
Sun Pharmaceutical Industries Ltd.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.